Featured News
![](/sites/default/files/styles/4_3_medium/public/2022/06/14/image%2059.png?itok=Ho2CIWYA)
AIM Blog
A New Era of Alzheimer’s Treatment and Care
When nearly 14,000 researchers recently joined for the Alzheimer’s Association International Conference (AAIC), the latest and greatest in Alzheimer’s and dementia research was on display. Throughout ...
All News
Press Release
Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means
— Congressional Bipartisan Support for Individuals, Families and Treatment on Display — WASHINGTON, D.C., May 10, 2023 — Today, Tony...
![Scientist at Microscope](/sites/default/files/styles/4_3_small/public/2022/12/20/Scientist-Using-Microscope-in-Laboratory-909176662_7360x4912%20%283%29_0.jpeg?itok=L4AC7J1K)
Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...
![Priya at capitol](/sites/default/files/styles/4_3_small/public/2023/04/25/Image.jpeg?itok=ZmEWm149)
AIM Blog
Recognizing AIM’s May Advocate of the Month: Priya Patel
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
![E&C hearing advocates](/sites/default/files/styles/4_3_small/public/2023/04/26/HearingAdvocates.jpg?itok=iuY2MykK)
Press Release
Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing
Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...
![petition graphic](/sites/default/files/styles/4_3_small/public/2023/04/21/ALZ_CMS%20Petition_1280x720_April%2021%202023%5B95%5D.png?itok=DRgos3tj)
AIM Blog
Sign the Petition: Urge President Biden to Tell CMS to Stop Blocking Access to Alzheimer’s Treatments
For over a year, the Centers for Medicare & Medicaid Services (CMS) has been blocking access to Food and Drug...
![Ernst district work period](/sites/default/files/styles/4_3_small/public/2023/04/12/Joni%20Ernst%20district%20work%20period.jpg?itok=OtJ2RkOn)
AIM Blog
Alzheimer’s Advocates Are Demanding Access to FDA-Approved Alzheimer’s Treatments
In communities across the nation, Alzheimer’s Association advocates are building on the momentum from the AIM Advocacy Forum and calling...